The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of denosumab from a phase III, randomized, active-controlled study compared with zoledronic acid in patients of Asian ancestry with bone metastases from solid tumors.
 
Zefei Jiang
No Relationships to Disclose
 
Zhimin Shao
Research Funding - GlaxoSmithKline; Pfizer; Roche
 
Qingyuan Zhang
No Relationships to Disclose
 
Yang Yao
Research Funding - Amgen; GlaxoSmithKline; Pfizer; Sanofi; Xian-Janssen Pharmaceutical
 
Jianxing He
No Relationships to Disclose
 
Wangjun Liao
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Yanmei Xu
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Jie Dong
Employment - GlaxoSmithKline
 
Li Zhang
No Relationships to Disclose